Catalyst Wire Dossier Catalyst Wire Dossier

Acellular pertussis vaccines containing genetically-detoxified pertussis toxin

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Acellular pertussis vaccines containing genetically-detoxified pertussis toxin, covering 2022-01-18 to 2022-01-18. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of 2 Doses Versus 1 Dose of Acellular Pertussis Vaccines Containing Genetically-detoxified Pertussis Toxin in Young Adults Previously Primed With Acellular Pertussis Vaccines [Phase 2, Phase 3]

See pricing